Two Cases of Inflammatory Bowel Disease Patients Treated With Ustekinumab 90 mg Every 3 Weeks

Inflamm Bowel Dis. 2020 Jan 6;26(2):e7. doi: 10.1093/ibd/izz291.

Authors

Thomas Chateau^{1

2}, Laurent Peyrin-Biroulet²

Affiliations

¹ Department of Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
² Department of Hepato-Gastroenterology, University Hospital of Grenoble, University of Grenoble Alpes, Grenoble, France.

PMID: 31769497
DOI: 10.1093/ibd/izz291

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Colitis, Ulcerative / drug therapy*
Dermatologic Agents / therapeutic use*
Female
Humans
Male
Prognosis
Ustekinumab / administration & dosage
Ustekinumab / therapeutic use*

Substances

Dermatologic Agents
Ustekinumab